Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients
about
sameAs
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron diseaseHarmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expressionInsulin-like growth factor-I for the treatment of amyotrophic lateral sclerosisCellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationNonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivoMolecular motor proteins and amyotrophic lateral sclerosisGlutamate transporter 1: target for the treatment of alcohol dependenceRedox regulation in amyotrophic lateral sclerosisExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsGlutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis modelsGamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisBMAA--an unusual cyanobacterial neurotoxin.A-to-I RNA editing and human disease.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisGlial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis.A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosisNeurotrophins and neurodegeneration.Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.A fruitful endeavor: modeling ALS in the fruit flyMolecular and cellular pathways of neurodegeneration in motor neurone diseaseMitochondria Related Pathway Is Essential for Polysaccharides Purified from Sparassis crispa Mediated Neuro-Protection against Glutamate-Induced Toxicity in Differentiated PC12 Cells.Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapiesBlood glutamate scavenging: insight into neuroprotection.Overview of Glutamatergic Dysregulation in Central Pathologies.Postactivation depression of the Ia EPSP in motoneurons is reduced in both the G127X SOD1 model of amyotrophic lateral sclerosis and in aged mice.Serotonergic mechanisms in amyotrophic lateral sclerosis.Mapping of FGF1 in the Medulla Oblongata of Macaca fascicularis.Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Regulation of synaptic transmission by ambient extracellular glutamateNeurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's diseaseSurvey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons.Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersNeuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).Anatomical recovery of the spinal glutamatergic system following a complete spinal cord injury in lampreysPotential therapeutic role of glutamate transporter 1 for the treatment of alcohol dependence.
P2860
Q24244456-AECE740D-159A-491E-865F-6106CE2AA3A4Q24595928-BDE2BCA2-5B4E-4D1A-92AD-E157C3834BC8Q24630353-521FE2CF-5374-46CC-8AE2-F5F39601A6E1Q24654460-223E1789-0393-43BE-A57B-14AED52D5EE0Q24675057-8B5AAA4A-1EA6-434B-B3F5-55FE00C4A255Q26820831-92E22062-D808-432A-BE16-463DCA37A6F4Q26861666-B7982852-297E-4661-81D6-BA973886415EQ27026894-AA6434AA-AEB5-4D3A-A2BC-A014FFA1BB95Q28075692-B3BD0CFF-ACCB-4D6B-A45C-4CAB0BA16AADQ28572282-5BB7A1DF-153B-4B25-99A5-577AC2F34261Q30239103-0B9073A1-E1F1-4566-A9EF-6C756C4615F6Q33767845-365188C1-4C65-43EC-B4FB-64416E6378D4Q33869419-15833C1A-F218-48CE-8969-D21D9093F234Q34006224-5FFCAEE1-4EFC-4739-9C21-35EBD7862FCBQ34020249-FD403F0C-F5A9-4EA0-B26F-34222C100409Q34162058-EE82C57F-33E5-4A8B-9FDD-8E72355622C2Q34344992-76157C0A-7CED-4BC6-B4C7-E7B171AEED24Q34550482-AB78818F-DB31-4B40-9441-0632D0E5A2FBQ34610044-C49D5F47-DFF1-47CD-BA96-D1CD16B3A744Q35145450-CCA3754A-86F0-43E2-B592-BB8113387849Q35147567-8E840604-0FC1-4877-9A3C-50614966F6B4Q35268719-D0164C64-E47D-4AEC-8ED8-F4B347CB84D7Q35489359-8CCE1838-B01C-4550-9CD5-A04CA80FAE87Q35907265-99CC78EF-7F3B-453E-A0D0-D60F27BE8D67Q35964723-66F6DB2B-582F-44FD-BB6C-6F3489AEA6D3Q36117639-4DC37598-B842-4B4C-B897-7A52FEC5FEF4Q36202424-BD5BA941-CC58-4B4D-992C-B4031B9EA28FQ36409596-11B525CB-ED0D-4949-8584-DB534DE9ED57Q36496962-8739C768-EC1F-4AEF-A3A8-54350BC62A7FQ36544155-53A28A80-354D-4D70-9103-DD97023FB1D1Q36561511-1F1972DF-EFDF-44C8-8A5E-2227B69E7556Q36565671-1FC05B04-0289-428B-A288-D3288E9961C2Q36569620-68D7E40F-A03B-4A24-8DC7-535046FDB21AQ36940103-7CF7AF4A-30E5-4663-94C3-8C9A3F724789Q36961660-CCC5AB8D-0AC4-4556-A328-2B3E1C9C2CB9Q37008837-FA4B33BA-3389-4D7A-9798-D6E4DF971C80Q37249765-EB3455A1-13A0-4480-B7AB-DBF5956E9932Q37394217-4810708A-0F76-434D-9A6B-CCF0BAB94957Q37439186-41885608-9BDF-448B-B47A-0B3EDE1AD31CQ37443749-5214DAD2-DAD4-429D-956B-5C3F11436C91
P2860
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glutamate levels in cerebrospi ...... in a large cohort of patients
@ast
Glutamate levels in cerebrospi ...... in a large cohort of patients
@en
Glutamate levels in cerebrospi ...... in a large cohort of patients
@nl
type
label
Glutamate levels in cerebrospi ...... in a large cohort of patients
@ast
Glutamate levels in cerebrospi ...... in a large cohort of patients
@en
Glutamate levels in cerebrospi ...... in a large cohort of patients
@nl
prefLabel
Glutamate levels in cerebrospi ...... in a large cohort of patients
@ast
Glutamate levels in cerebrospi ...... in a large cohort of patients
@en
Glutamate levels in cerebrospi ...... in a large cohort of patients
@nl
P2093
P3181
P1476
Glutamate levels in cerebrospi ...... in a large cohort of patients
@en
P2093
Abdellatif Marouan
François Salachas
Gilbert Bensimon
Lucette Lacomblez
Michel Dib
Nadine Le Forestier
Odile Spreux-Varoquaux
P3181
P356
10.1016/S0022-510X(01)00661-X
P407
P577
2002-01-15T00:00:00Z